Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Astellas Pharma Europe Ltd.

Clinical trials sponsored by Astellas Pharma Europe Ltd., explained in plain language.

Easier pill for transplant kids? study tests new daily dose

Disease control Completed

This study tested if switching children with stable organ transplants from a twice-daily anti-rejection pill (Prograf) to a new once-daily version (Advagraf) was safe and kept the right amount of medicine in their blood. It involved 81 children who had received a heart, kidney, l…

Phase: PHASE2 • Sponsor: Astellas Pharma Europe Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC